Literature DB >> 28518116

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections.

William J Comstock1, Edwin Huh2, Reiley Weekes2, Connor Watson2, Tianyang Xu2, Pieter C Dorrestein1, Robert A Quinn3.   

Abstract

Many chronic airway diseases result in mucus plugging of the airways. Lungs of an individual with cystic fibrosis are an exemplary case where their mucus-plugged bronchioles create a favorable habitat for microbial colonization. Various pathogens thrive in this environment interacting with each other and driving many of the symptoms associated with CF disease. Like any microbial community, the chemical conditions of their habitat have a significant impact on the community structure and dynamics. For example, different microorganisms thrive in differing levels of oxygen or other solute concentrations. This is also true in the CF lung, where oxygen concentrations are believed to drive community physiology and structure. The methods described here are designed to mimic the lung environment and grow pathogens in a manner more similar to that from which they cause disease. Manipulation of the chemical surroundings of these microbes is then used to study how the chemistry of lung infections governs its microbial ecology. The method, called the WinCF system, is based on artificial sputum medium and narrow capillary tubes meant to provide an oxygen gradient similar to that which exists in mucus-plugged bronchioles. Manipulating chemical conditions, such as the media pH of the sputum or antibiotics pressure, allows for visualization of the microbiological differences in those samples using colored indicators, watching for gas or biofilm production, or extracting and sequencing the nucleic acid contents of each sample.

Entities:  

Mesh:

Year:  2017        PMID: 28518116     DOI: 10.3791/55532

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  6 in total

Review 1.  Targeting Persistent Biofilm Infections: Reconsidering the Topography of the Infection Site during Model Selection.

Authors:  Ilana Kolodkin-Gal; Malena Cohen-Cymberknoh; Gideon Zamir; Igor Tsesis; Eyal Rosen
Journal:  Microorganisms       Date:  2022-06-06

2.  Model Systems to Study the Chronic, Polymicrobial Infections in Cystic Fibrosis: Current Approaches and Exploring Future Directions.

Authors:  George A O'Toole; Aurélie Crabbé; Rolf Kümmerli; John J LiPuma; Jennifer M Bomberger; Jane C Davies; Dominique Limoli; Vanessa V Phelan; James B Bliska; William H DePas; Lars E Dietrich; Thomas H Hampton; Ryan Hunter; Cezar M Khursigara; Alexa Price-Whelan; Alix Ashare; Robert A Cramer; Joanna B Goldberg; Freya Harrison; Deborah A Hogan; Michael A Henson; Dean R Madden; Jared R Mayers; Carey Nadell; Dianne Newman; Alice Prince; Damian W Rivett; Joseph D Schwartzman; Daniel Schultz; Donald C Sheppard; Alan R Smyth; Melanie A Spero; Bruce A Stanton; Paul E Turner; Chris van der Gast; Fiona J Whelan; Rachel Whitaker; Katrine Whiteson
Journal:  mBio       Date:  2021-09-21       Impact factor: 7.786

Review 3.  The Microbiome in Cystic Fibrosis Pulmonary Disease.

Authors:  Alice Françoise; Geneviève Héry-Arnaud
Journal:  Genes (Basel)       Date:  2020-05-11       Impact factor: 4.096

4.  High-Resolution Longitudinal Dynamics of the Cystic Fibrosis Sputum Microbiome and Metabolome through Antibiotic Therapy.

Authors:  Ruma Raghuvanshi; Karla Vasco; Yoshiki Vázquez-Baeza; Lingjing Jiang; James T Morton; Danxun Li; Antonio Gonzalez; Lindsay DeRight Goldasich; Gregory Humphrey; Gail Ackermann; Austin D Swafford; Douglas Conrad; Rob Knight; Pieter C Dorrestein; Robert A Quinn
Journal:  mSystems       Date:  2020-06-23       Impact factor: 6.496

5.  Niche partitioning of a pathogenic microbiome driven by chemical gradients.

Authors:  Robert A Quinn; William Comstock; Tianyu Zhang; James T Morton; Ricardo da Silva; Alda Tran; Alexander Aksenov; Louis-Felix Nothias; Daniel Wangpraseurt; Alexey V Melnik; Gail Ackermann; Douglas Conrad; Isaac Klapper; Rob Knight; Pieter C Dorrestein
Journal:  Sci Adv       Date:  2018-09-26       Impact factor: 14.136

6.  Complex and unexpected outcomes of antibiotic therapy against a polymicrobial infection.

Authors:  Lydia-Ann J Ghuneim; Ruma Raghuvanshi; Kerri A Neugebauer; Douglas V Guzior; Martin H Christian; Bella Schena; Jeremiah M Feiner; Alicia Castillo-Bahena; Jenna Mielke; Marc McClelland; Douglas Conrad; Isaac Klapper; Tianyu Zhang; Robert A Quinn
Journal:  ISME J       Date:  2022-05-21       Impact factor: 11.217

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.